31-Dec-2025
No headlines found.
Cabot Corporation Announces Reinforcement Materials Segment Executive Transition
Globe Newswire (Fri, 21-Nov 9:00 AM ET)
Cabot Corporation's LITX 95F Conductive Carbon Named One of the "Top 10 Exhibits of 2025" at CIIE
Globe Newswire (Tue, 18-Nov 9:00 AM ET)
Cabot Corporation Board Declares Dividend
Globe Newswire (Thu, 13-Nov 6:30 PM ET)
Cabot Corp Reports Fourth Quarter and Fiscal Year 2025 Results
Globe Newswire (Mon, 3-Nov 4:30 PM ET)
Globe Newswire (Mon, 3-Nov 4:30 PM ET)
Globe Newswire (Tue, 7-Oct 9:00 AM ET)
Cabot Corporation to Announce Fourth Quarter 2025 Operating Results
Globe Newswire (Fri, 3-Oct 8:16 AM ET)
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into the following operating segments based on the product type; the Reinforcement Materials segment which generates maximum revenue provides reinforcing carbon products used in tires, and industrial products such as hoses, belts, extruded profiles, and molded goods; and the Performance Chemicals segment aggregates the specialty carbons, specialty compounds, fumed metal oxides, battery materials, inkjet colorants, and aerogel product lines. Geographically, the company derives maximum revenue from its customers in Europe, the Middle East, and Africa and the rest from the Americas and Asia Pacific region.
Cabot trades on the NYSE stock market under the symbol CBT.
As of December 31, 2025, CBT stock price declined to $66.28 with 319,173 million shares trading.
CBT has a beta of 0.73, meaning it tends to be less sensitive to market movements. CBT has a correlation of 0.26 to the broad based SPY ETF.
CBT has a market cap of $3.51 billion. This is considered a Mid Cap stock.
Last quarter Cabot reported $899 million in Revenue and $1.70 earnings per share. This fell short of revenue expectation by $-62 million and exceeded earnings estimates by $.01.
In the last 3 years, CBT traded as high as $117.46 and as low as $58.33.
The top ETF exchange traded funds that CBT belongs to (by Net Assets): IJH, AVUV, VTI, IWM, VB.
CBT has underperformed the market in the last year with a price return of -24.9% while the SPY ETF gained +17.2%. CBT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.3% and -2.5%, respectively, while the SPY returned +2.7% and +0.7%, respectively.
CBT support price is $65.33 and resistance is $67.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBT shares will trade within this expected range on the day.